Temporal patterns of drug‐eluting stent failure and its relationship with clinical outcomes

We investigated the temporal patterns of drug‐eluting stents (DES) failure and its relationship with clinical outcomes in patients with DES failure.

[1]  M. Kimura,et al.  Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. , 2013, European heart journal cardiovascular Imaging.

[2]  A. Kastrati,et al.  Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.

[3]  Soo-Jin Kang,et al.  In-stent neoatherosclerosis: a final common pathway of late stent failure. , 2012, Journal of the American College of Cardiology.

[4]  I. Seong,et al.  Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation. , 2012, Journal of the American College of Cardiology.

[5]  Seung‐Jung Park,et al.  Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation , 2011, Circulation.

[6]  F. Eberli,et al.  Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial , 2011, Circulation.

[7]  M. Kimura,et al.  Difference of Tissue Characteristics Between Early and Very Late Restenosis Lesions After Bare-Metal Stent Implantation: An Optical Coherence Tomography Study , 2011, Circulation. Cardiovascular interventions.

[8]  Masataka Nakano,et al.  The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. , 2011, Journal of the American College of Cardiology.

[9]  Seung‐Jung Park,et al.  Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation: Intravascular Ultrasound Analysis , 2011, Circulation. Cardiovascular interventions.

[10]  Seung‐Jung Park,et al.  Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. , 2010, The American journal of cardiology.

[11]  P. Serruys,et al.  Coronary stents: current status. , 2010, Journal of the American College of Cardiology.

[12]  Y. Hayashi,et al.  Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). , 2010, The American journal of cardiology.

[13]  Seung‐Jung Park,et al.  Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. , 2010, Journal of the American College of Cardiology.

[14]  G. Lemesle,et al.  Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. , 2009, Archives of cardiovascular diseases.

[15]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[16]  S. Markwell,et al.  Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. , 2007, Journal of the American College of Cardiology.

[17]  A. Colombo,et al.  Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. , 2006, European heart journal.

[18]  G. Biondi-Zoccai,et al.  Drug-eluting stent restenosis the pattern predicts the outcome. , 2006, Journal of the American College of Cardiology.

[19]  Deepak L. Bhatt,et al.  Bare metal stent restenosis is not a benign clinical entity. , 2006, American heart journal.

[20]  Seung‐Jung Park,et al.  Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. , 2006, American Journal of Cardiology.

[21]  A. Kastrati,et al.  Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005, JAMA.

[22]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[23]  S. Silber,et al.  Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions , 2003, Circulation.

[24]  R. Choussat,et al.  In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. , 2000, Journal of the American College of Cardiology.

[25]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.

[26]  J. Alpert,et al.  The third universal definition of myocardial infarction , 2013 .

[27]  Ousa,et al.  A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .